Tag: Invisible Warriors

The landscape of cancer immunotherapy has witnessed a pivotal advancement this October, as researchers from MIT and Harvard Medical School unveiled a novel engineering approach that transforms natural killer (NK) cells into sophisticated cancer-fighting agents capable of evading immune rejection. This breakthrough addresses one of cellular immunotherapy’s most persistent challenges: the host immune system’s tendency…